Legacy Advisors, LLC Illumina, Inc. Transaction History

Legacy Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $3,480 - $5,195	27 Added 1.06%	2,584 $354,000
Q2 2023 Jul 20, 2023	BUY	$183.43 - $232.67 $25,863 - $32,806	141 Added 5.84%	2,557 $479,000
Q1 2023 May 01, 2023	BUY	$193.75 - $232.55 $29,643 - $35,580	153 Added 6.76%	2,416 $561,000
Q4 2022 Feb 01, 2023	BUY	$187.24 - $242.74 $103,169 - $133,749	551 Added 32.18%	2,263 $457,000
Q3 2022 Nov 09, 2022	BUY	$177.23 - $227.44 $97,830 - $125,546	552 Added 47.59%	1,712 $327,000
Q2 2022 Jul 25, 2022	BUY	$181.58 - $368.0 $55,200 - $111,872	304 Added 35.51%	1,160 $214,000
Q1 2022 May 11, 2022	BUY	$303.87 - $423.8 $245,526 - $342,430	808 Added 1683.33%	856 $299,000
Q1 2019 Apr 08, 2019	BUY	$272.57 - $321.18 $13,083 - $15,416	48 New	48 $15,000
Q4 2018 Jan 14, 2019	SELL	$272.46 - $366.54 $17,982 - $24,191	-66 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$279.04 - $367.06 $5,022 - $6,607	18 Added 37.5%	66 $24,000
Q3 2017 Nov 03, 2017	BUY	$172.3 - $213.93 $8,270 - $10,268	48	48 $9,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Advisors, LLC with notifications on news.